Trial Profile

Justification for Atherosclerosis Regression Treatment [JART Extension Study]

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 17 May 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Rosuvastatin (Primary) ; Pravastatin
Indications Atherosclerosis; Hypercholesterolaemia
Focus Therapeutic Use
Acronyms JART

Most Recent Events

29 Aug 2012 Results of an analysis of the extension study (n=118) presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
16 Nov 2011 Results published in Circulation Journal.
31 Aug 2011 Actual patient number (n=295) reported in an abstract presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com